| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.35B | 20.00B | 19.56B | 17.97B | 14.98B | 14.12B |
| Gross Profit | 6.61B | 3.98B | 2.82B | 3.99B | 3.79B | 3.35B |
| EBITDA | 2.42B | 2.29B | 1.72B | 1.21B | 1.73B | 1.48B |
| Net Income | 1.51B | 1.42B | 1.02B | 632.11M | 1.07B | 939.03M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 18.98B | 17.13B | 16.96B | 13.96B | 14.26B |
| Cash, Cash Equivalents and Short-Term Investments | 666.26M | 666.26M | 613.50M | 196.42M | 360.96M | 81.44M |
| Total Debt | 0.00 | 1.05B | 873.09M | 1.63B | 539.50M | 1.00B |
| Total Liabilities | -10.85B | 8.14B | 7.00B | 7.78B | 5.27B | 6.06B |
| Stockholders Equity | 10.85B | 10.85B | 10.14B | 9.18B | 8.70B | 8.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 561.68M | 1.35B | -980.91M | 675.70M | 1.07B |
| Operating Cash Flow | 0.00 | 934.57M | 1.84B | -106.33M | 1.35B | 1.55B |
| Investing Cash Flow | 0.00 | -377.20M | -429.91M | -864.03M | 93.09M | -1.13B |
| Financing Cash Flow | 0.00 | -610.92M | -980.58M | 796.80M | -1.15B | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹9.67B | 15.41 | ― | 1.06% | 16.68% | 15.13% | |
68 Neutral | ₹22.86B | 6.89 | ― | 2.00% | 17.71% | 18.17% | |
66 Neutral | ₹1.82B | 4.93 | ― | ― | 8.83% | 160.77% | |
64 Neutral | ₹18.52B | 12.46 | ― | 0.71% | 6.86% | 15.64% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | ₹22.10B | -12.89 | ― | ― | -11.72% | -439.12% | |
46 Neutral | ₹286.52M | ― | ― | ― | ― | ― |
Insecticides (India) Limited has notified the stock exchanges that, in line with a SEBI circular governing the special window for re-lodgement of transfer requests for physical shares, it has received a status report from its Registrar and Share Transfer Agent, Alankit Assignments Limited, as of December 31, 2025. The report confirms that during the relevant period there were no shareholder requests for re-lodgement of transfers of physical share certificates, resulting in no approvals or rejections and no processing time recorded, indicating that the company’s share transfer activity has effectively transitioned away from physical share transfer requests under the current regulatory framework.
Insecticides (India) Limited has released its earnings presentation for the second quarter and half-year of the fiscal year 2025-26, ending on September 30, 2025. This release is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning within the agrochemical industry, potentially impacting investor decisions and market perception.